热门资讯> 正文
上诉法院恢复牙科矫正公司反垄断指控，Align Technology受到打击
2026-10-06 04:22
- Align Technology (ALGN), the maker of Invisalign, was dealt a blow on Monday after a federal appeals court reversed a lower court ruling that granted the company summary judgment.
- The decision means that Align will likely again face claims that it held a monopoly for clear dental aligners. The company was sued by consumers and dental practices.
- The US Court of Appeals for the Ninth Circuit found that the lower court made a mistake as plaintiffs provided sufficient evidence that Align minimized competition for their aligners as well as digital image scanners used to make the aligners by measuring a patient's jaw, teeth, and bite, Bloomberg Law reported.
More on Align Technology
- Align Technology, Inc. (ALGN) Presents at 2026 Global Healthcare Conference Transcript
- Align Technology: DCF Signals Overvaluation Despite Long-Term Growth Potential
- Align Technology: A Structurally Better Business Trading At A Structurally Lower Multiple
- 10 large and mega-cap U.S. healthcare stocks with the weakest momentum grades
- Align wins China patent ruling against Angelalign
推荐文章
新股申购 | “非洲手机之王”传音控股今启招股！一手入场费3919.13港元
10月7日外盘头条：Anthropic扩大先进AI模型访问权限 Meta和沃尔玛制定个人代理协议 法国25万人参加抗议活动
Meta推出Muse利好AMD，AI浪潮重心转向个人智能代理
美股前瞻 | 三大期指齐升，纳指开盘势再创新高！大摩看高SpaceX至300美元；AMD苏姿丰喊话将持续大幅扩产；迈威尔科技21点举行投资者日
一图看懂 | 潘渡SOL ETF开启申购！紧密追踪Solana价格表现
Anthropic营收增长面临挑战，微软和Meta据悉限制员工使用Claude模型
30年期收益率本月将破6%？经济韧性与通胀压力推高利率 美债抛售潮进一步加剧
美股前瞻 | 美联储10月加息概率已不足25%；台积电盘前涨2%开盘将创新高；高通与华为达成重磅专利协议
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
